补肺活血汤联合常规西医治疗可降低气道炎症并改善肺功能从而提高COPD的疗效

摘要

Objective:To analyze Bufei Huo Xue Tang combined with Western medicine for chronic obstructive pulmonary disease( COPD) and its effect on airway inflammation reduction and lung function improvement. Methods: 100 patients with stable COPD in our department from February 2013 to March 2015 were randomly divided into combination group and control group. The control group received conventional oxygen,salmeterol and fluticasone propionate inhalation powder(1 absorption /times,2 times /day) and expectorant treatment. Combination group were based on the addition of lungs Bufei Huo Xue Tang with a course of 12 weeks. The clinical efficacy and α1-AT and IL-8 levels in two groups of patients were compared. Results:The cough,sputum,difficulty breathing, wheezing,wheezing symptom score in the combined group after treatment was significantly lower than the control group ( P<0. 05 ) . FVC,FEV1 and FEV1 /FVC in the combined group after treatment was significantly lower than those in the control group(P<0. 05).α1-AT and NO in the combination group was significantly higher after treatment. IL-8 and TNF-α was significantly lower than the control group(P<0. 05). BODE scores in the combined group after treatment were significantly lower than the control group(P<0. 05). Conclusion:Bufei Huoxue soup combined with Western medicine for COPD can inhibit inflammation,improve clinical symptoms,lung function and quality of life.%目的：：分析补肺活血汤联合西医治疗慢性阻塞性肺疾病( Chronic obstructive pulmonary disease,COPD)稳定期的疗效及降低气道炎症并改善肺功能的作用。方法：选取我科2013年2月至2015年3月COPD稳定期患者共100例,随机分为联合组和对照组。对照组予以常规吸氧、沙美特罗替卡松粉吸入剂(1吸/次,2次/d)及祛痰治疗。联合组在对照组基础上,加用补肺活血汤,疗程均为12周。对比两组患者的临床疗效及α1-AT和IL-8水平变化。结果：联合组治疗后的咳嗽、咳痰、呼吸困难、喘息、哮鸣症状积分显著低于对照组(P<0.05)。联合组治疗后的用力肺活量(Forced vital capacity,FVC)、一秒用力呼气容积(Forced expiratory volume in one second,FEV1)和FEV1/FVC显著低于对照组(P<0.05)。联合组治疗后的α1-AT和NO显著高于对照组,IL-8和TNF-α显著低于对照组(P<0.05)。联合组治疗后的BODE各项评分显著低于对照组(P<0.05)。结论：补肺活血汤联合西医治疗COPD可通过抑制炎症反应,改善临床症状、肺功能和生活质量。